Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Cardiovascular health. stories

Oct 20, 2026

Scientists discover statins cause muscle pain through calcium leak mechanism

Researchers using advanced imaging technology have uncovered why statins, widely prescribed cholesterol-lowering drugs, can cause muscle pain, weakness, and in rare cases severe muscle damage. The discovery reveals a previously unknown mechanism involving calcium leaks in muscle cells.

Oct 20, 2026·1 source
00
Oct 15, 2026

Intensive blood pressure lowering reduces cardiovascular risk without increasing kidney failure

A meta-analysis of 27 trials found that intensive blood pressure lowering reduced cardiovascular risk by 15% per 10 mm Hg reduction in systolic blood pressure, with no added risk of kidney failure, even in patients with chronic kidney disease.

Oct 15, 2026·2 sources
00
Oct 11, 2026

Managing high blood pressure could prevent over 500,000 cardiovascular deaths annually, study finds

Research presented at the American Heart Association's Hypertension Scientific Sessions 2026 shows that effective management of high blood pressure could prevent more than 518,000 annual deaths from cardiovascular disease across 20 countries worldwide.

Oct 11, 2026·1 source
00
Oct 5, 2026

ARPA-H awards over $100 million to four organizations for biosensor development projects

The Advanced Research Projects Agency for Health has awarded more than $100 million to four organizations—MIT, Novelna, NYU, and the University of Washington—to develop biosensor devices for tracking heart disease, inflammation, and perimenopause.

Oct 5, 2026·2 sources
00
Sep 30, 2026

Eli Lilly's Foundayo demonstrates cardiovascular safety in ACHIEVE-4 diabetes trial

Eli Lilly's oral GLP-1 drug Foundayo (orforglipron) met its primary cardiovascular safety endpoint in the Phase 3 ACHIEVE-4 trial, showing non-inferiority to insulin glargine in adults with type 2 diabetes and obesity. The study found a 16% lower risk of MACE-4 and 23% lower risk of MACE-3, though cardiovascular benefits remain unproven.

Sep 30, 2026·6 sources
00
Sep 28, 2026

Blood pressure variability linked to higher death and stroke risk in UK Biobank study

Analysis of more than 57,000 UK Biobank participants found that greater variation in blood pressure measurements between research visits was associated with increased risk of death, with some blood pressure measures also linked to stroke risk. The findings were presented at the European Association for the Study of Diabetes annual meeting.

Sep 28, 2026·4 sources
00

Noninvasive ear nerve stimulation shows promise for uncontrolled high blood pressure in SCRATCH-HTN trial

A clinical trial led by Queen Mary University of London has found that transcutaneous autonomic neuromodulation through the ear is safe, well-tolerated, and easy for patients with uncontrolled hypertension to use at home. The SCRATCH-HTN trial demonstrates the potential of this noninvasive technique as a treatment option for high blood pressure.

Sep 28, 2026·3 sources
00
Sep 23, 2026

Oral menopausal hormone therapy linked to increased blood clot risk, Danish study finds

A nationwide Danish study found that oral menopausal hormone therapy is associated with elevated risk of venous thromboembolism regardless of dose, while high-dose oral forms also increased stroke and heart attack risk. Transdermal treatments showed no overall increase in thrombotic risk.

Sep 23, 2026·3 sources
00
Sep 20, 2026

Man who weighed 49 stone loses 32 stone after doctor's warning during heart surgery

A 46-year-old father standing 6ft 8in tall lost 32 stone after doctors warned him during open-heart surgery that his weight was endangering his life. He now believes he has the best chance of staying with his family.

Sep 20, 2026·1 source
00

French study links eight common food preservatives to high blood pressure and heart disease

Researchers have identified eight widely used food preservatives in processed foods that are associated with significantly higher rates of hypertension and cardiovascular disease, according to a large observational study conducted in France.

Sep 20, 2026·2 sources
00
Sep 17, 2026

Systemic lupus erythematosus linked to increased risk for stroke

A systematic review found that systemic lupus erythematosus (SLE) is associated with an increased risk for stroke, including both ischemic and hemorrhagic stroke types.

Sep 17, 2026·1 source
00
Sep 11, 2026

Nighttime light exposure linked to thicker heart chambers and reduced function

Study of over 11,000 people found nighttime light exposure associated with thicker, stiffer heart chambers and early signs of reduced heart function, suggesting keeping bedrooms darker may benefit cardiovascular health.

Sep 11, 2026·2 sources
00
Sep 9, 2026

New research highlights benefits and risks of hormone therapy for menopause symptoms

Multiple studies released this week show hormone therapy during menopause may reduce heart disease risk and improve mood symptoms, while supplements marketed for menopause lack evidence and contain inconsistent doses. The research comes amid growing attention to the economic costs of menopause symptoms for women.

Sep 9, 2026·5 sources
00
Aug 18, 2026

SINGLE-AF trial finds blood thinners cut stroke risk 69% in atrial fibrillation patients

The randomized SINGLE-AF trial, presented at ESC Congress 2026 and published in the New England Journal of Medicine, found that direct oral anticoagulants reduced serious clinical events by 69% in atrial fibrillation patients with intermediate stroke risk. The benefit was primarily driven by fewer ischemic strokes, with no increase in major bleeding.

Aug 18, 2026·3 sources
00
Aug 6, 2026

New research reveals biological mechanism behind preeclampsia, offering path toward potential cure

Scientists have made a breakthrough in understanding the biology that triggers preeclampsia, a dangerous pregnancy complication that doubles women's risk of premature cardiovascular death and is a leading cause of maternal mortality and preterm birth.

Aug 6, 2026
00
Aug 5, 2026

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

New research published in The BMJ shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist, reduces the risk of major cardiovascular events by 33% in type 2 diabetes patients with existing heart disease. A separate study also found that consistent medication adherence among diabetes patients reduces heart disease risk by 27%.

Aug 5, 2026·11 sources
00

Study finds Mounjaro reduces heart attack risk by 33% in type 2 diabetes patients with heart disease

New research indicates that Mounjaro (tirzepatide) significantly lowers the risk of heart attacks in type 2 diabetes patients who also have heart disease, with a 33% reduction observed in those receiving the medication.

Aug 5, 2026·1 source
00

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

New research published in The BMJ shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist, reduces the risk of major cardiovascular events by 33% in type 2 diabetes patients with existing heart disease. A separate study also found that consistent medication adherence among diabetes patients reduces heart disease risk by 27%.

Aug 5, 2026·9 sources
00

Mounjaro Found to Reduce Heart Attack Risk by 33% in Type 2 Diabetes Patients with Heart Disease

A new study shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist drug, reduces heart attack risk by 33% when added to standard care for patients with both type 2 diabetes and existing heart disease. The findings come as worldwide sales of the drug doubled to £13.8 billion in the first half of 2026.

Aug 5, 2026·5 sources
00

UCLA Study Identifies SARS-CoV-2 Protein That May Explain Long COVID Mechanisms

UCLA researchers led by Melody Li have discovered that the SARS-CoV-2 nucleocapsid protein can suppress early antiviral responses while triggering inflammation that damages blood vessels, potentially explaining long COVID symptoms. The finding comes as separate research explores viral reactivation and psychosocial factors in long COVID patients.

Aug 5, 2026·8 sources
00
Aug 4, 2026

FDA Authorizes Caristo's AI Tool for Cardiovascular Risk Assessment

The University of Oxford spinout Caristo has received FDA authorization for an AI-powered tool designed to assess heart attack risk in patients without obstructive coronary artery disease. The company plans to launch the cardiovascular risk predictor soon.

Aug 4, 2026·1 source
00
Jul 31, 2026

Daily avocado consumption may lower heart disease risk in obese adults

A six-month clinical trial found that eating one avocado daily reduced the number of LDL particles circulating in the blood of adults with obesity, potentially lowering heart disease risk.

Jul 31, 2026·1 source
00

Scientists identify immune response that may explain statin muscle pain

Researchers have identified an immune response that may explain why statins cause muscle pain, weakness, and exercise intolerance in some patients. The finding could eventually lead to treatments that prevent these side effects.

Jul 31, 2026·1 source
00

Novo Nordisk's experimental drug fails to reduce heart attacks and strokes in large study

Novo Nordisk's experimental inflammation-targeting drug failed to reduce the risk of heart attacks and strokes in a closely watched large clinical trial, a setback for the drugmaker's growth prospects beyond obesity and diabetes.

Jul 31, 2026·2 sources
00
Jul 28, 2026

Remdesivir treatment reduces cardiovascular complications in kidney transplant recipients with COVID-19

Study finds that kidney transplant recipients treated with remdesivir within a week of COVID-19 diagnosis and receiving at least three consecutive days of therapy experienced fewer cardiovascular complications compared to those who did not receive the antiviral treatment.

Jul 28, 2026·1 source
00

New Sticker-Sized Pacemaker Uses Ultrasound Technology Instead of Traditional Wires

A novel pacemaker design the size of a sticker employs ultrasound technology rather than conventional wires to treat cardiac arrhythmia, offering a potential alternative to standard surgical pacemaker implantation for millions of patients worldwide.

Jul 28, 2026·1 source
00
Jul 27, 2026

UCT Clinicians Warn of Health Dangers from Pre-Workout Supplements After Emergency Case

Researchers at the University of Cape Town have issued a warning about potential health risks associated with pre-workout supplements following a case where an adult patient presented to the emergency unit with chest pain.

Jul 27, 2026·1 source
00
Jul 25, 2026

FDA's voluntary sodium reduction targets show minimal impact three years after implementation

The U.S. Food and Drug Administration's Phase I voluntary sodium reduction targets, issued in 2021 to encourage manufacturers to lower sodium in packaged foods by 2024, appear to have had minimal effect on reducing sodium levels in food products.

Jul 25, 2026·1 source
00
Jul 23, 2026

Lifestyle Media Outlets Publish Guides on Bicycle Commuting Safety and Best Practices

Multiple news outlets published practical guides on bicycle commuting, featuring advice on safety, preparation, and arriving presentable at work. The articles highlight Chicago pub owner Michael Roper, 72, as an example of successful bike commuting.

Jul 23, 2026·4 sources
00
Jul 21, 2026

Nearly All US Heart Disease Deaths Linked to Modifiable Risk Factors, New Research Shows

A new study published in JAMA Cardiology reveals that approximately 90% of ischemic heart disease deaths in the United States remain attributable to modifiable risk factors including blood pressure, diet, and LDL cholesterol, despite significant declines in mortality since 1990. Research also shows these factors are linked to unstable coronary artery plaques that lead to heart attacks.

Jul 21, 2026·4 sources
00
Jul 16, 2026

Merck wins FDA approval for first oral PCSK9 cholesterol pill

Merck received FDA approval for its oral PCSK9 inhibitor cholesterol pill, the first of its kind, offering a more convenient alternative to existing injectable therapies for high-risk patients.

Jul 16, 2026·4 sources
00
Jul 12, 2026

US Senator Lindsey Graham dies at 71 from aortic dissection

Lindsey Graham, the longtime Republican senator from South Carolina and prominent Trump ally, has died following an aortic dissection, according to preliminary findings from the Washington, DC medical examiner.

Jul 12, 2026·8 sources
00
Apr 29, 2026

Bariatric Surgery Shows Greater Long-Term Cardiovascular Benefits Than GLP-1 Weight-Loss Medications

Mayo Clinic study finds metabolic and bariatric surgery provides significantly greater long-term cardiovascular risk reduction compared to GLP-1 medications in people with obesity, despite both treatments improving heart health.

Apr 29, 2026·1 source
00
Apr 28, 2026

High-Precision Radiation Therapy Reduces Life-Threatening Heart Arrhythmias by 80%

Two studies report that targeted, noninvasive radiation therapy (proton beam therapy) reduced episodes of life-threatening cardiac arrhythmias by nearly 80% in critically ill patients, representing the first large-scale and first-in-human evidence for this approach.

Apr 28, 2026·2 sources
00
Apr 25, 2026

Sudden Deaths Across Europe Rose 30% Over Decade, with Sharper Increase Among Women

A study published in The Lancet found over 2.5 million sudden deaths—natural unexpected deaths occurring within one hour of symptom onset—occurred across 26 European countries from 2010 to 2020, representing a 30% increase with a disproportionately sharper rise among women.

Apr 25, 2026·1 source
00
Apr 23, 2026

Low-Dose Triple-Pill Combination Reduces Recurrent Stroke Risk by 40% in Global Trial

A global clinical trial found that GMRx2, a single pill combining three low-dose blood pressure medications, significantly reduced the risk of recurrent stroke in patients with intracerebral hemorrhage and high blood pressure by approximately 40%.

Apr 23, 2026·1 source
00

Top claims

  • ▪A study led by University of British Columbia researchers showed three statin molecules occupy a pocket in the RyR1 channel, with two holding the channel open to allow calcium leakage.
  • ▪Researchers at the University of British Columbia stated that structural insights into statin binding on RyR1 proteins provide a roadmap for designing modified statins that do not damage muscle tissue.
  • ▪More than 200 million people worldwide use statins to lower cholesterol and prevent heart attacks and strokes, according to a study published.

People involved

Donald Trump

Subtopics

Drug Approval and Clinical Trials16Drug Policy, Pricing & Approval16Clinical trials5GLP-1 medications5Preventive medicine4GLP-1 / Weight-Loss Medications3Lifestyle, Wellness and Nutrition3Longevity & biohacking3Nutrition fundamentals3Obesity treatment3Weight management3Blood pressure management2Cholesterol management2Diet & nutrition2Medication adherence2Pharma2Public health2Public healthcare2Statins2Supplement regulation2Women’s health2AI in healthcare1AI Regulation1AI startups1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories